Anika Therapeutics Q1 2024 Adj EPS $0.09 Beats $(0.19) Estimate, Sales $40.523M Beat $39.143M Estimate
Author: Benzinga Newsdesk | May 08, 2024 04:11pm
Anika Therapeutics (NASDAQ:
ANIK) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.19) by 147.37 percent. The company reported quarterly sales of $40.523 million which beat the analyst consensus estimate of $39.143 million by 3.53 percent. This is a 6.85 percent increase over sales of $37.924 million the same period last year.
Posted In: ANIK